McKesson Europe AG
McKesson Europe AG (CAKFY) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cakfy · pe ratio · data through Mar 31, 2022
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for McKesson Europe AG (CAKFY) measures how much investors pay for each dollar of the company's trailing earnings. CAKFY's current PE ratio of N/A is calculated by dividing its stock price of $4.10 by its TTM earnings per share of -$0.05.
Source: FMP · /ratios-ttm · /analyst-estimates · 2022-03-31
PE Ratio History
2002 – 2022 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 13 fiscal years · Front-end computedMinQ1 · 25%20.6x
MedianQ3 · 75%6014.8x
Max
At N/A, CAKFY's current P/E is lower than in 0% of its annual fiscal year readings over the past 13 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Distribution · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
McKesson Europe AGYou CAKFY | $5.4B | N/A | — | -$0.05 |
 Abcam plc ABCZF | $5.1B | N/A | — | $0.00 |
 Mediclinic International plc ANHGY | $4.0B | N/A | — | — |
 Alfresa Holdings Corporation ARHCF | $2.2B | 8.15x | — | $231.09 |
 Ascentage Pharma Group International ASPHF | $1.7B | N/A | — | -$3.40 |
 Dechra Pharmaceuticals PLC DCHPF | $5.3B | N/A | — | -$0.25 |
 Dechra Pharmaceuticals PLC DPHAY | $5.6B | N/A | — | -$0.25 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2022-03-31Latest FY2022 | — | $-0.05 | — | |
2021-03-31 FY2021 | 6014.78x | $0.00 | — | |
2020-03-31 FY2020 | — | $-0.07 | — | |
2019-03-31 FY2019 | — | $-0.06 | — | |
2018-03-31 FY2018 | — | $-0.29 | — | |
2017-03-31 FY2017 | — | $-0.95 | — | |
2016-03-31 FY2016 | 12.83x | $0.39 | -88.1% | |
2014-12-31 FY2014 | 108.29x | $0.05 | +345.9% | |
2013-12-31 FY2013 | 24.28x | $0.19 | — | |
2012-12-31 FY2012 | — | $-0.18 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for McKesson Europe AG (CAKFY) measures how much investors pay for each dollar of the company's trailing earnings. CAKFY's current PE ratio of N/A is calculated by dividing its stock price of $4.10 by its TTM earnings per share of -$0.05.
Frequently asked questions
CAKFY pe ratio · 6 questionsCAKFY's current PE ratio is N/A as of 2026-06-08, based on a stock price of $4.10 and TTM EPS of -$0.05. Data sourced from Financial Modeling Prep via CAKFY's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · McKesson Europe AG SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08